Effective April 15, patients may bring one visitor to an appointment.
Learn more about this and other COVID-19 related updates

Clinical Trials & Research

Ph2 A+AVD +G-CSF or AOAD in CHL

SGN35-027: Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

Disease Types: Lymphomas,&nbs

Available at: {clinical_trial_location backspace="7"}Ph2 A+AVD +G-CSF or AOAD in CHL, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}